These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 15815752)
21. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [TBL] [Abstract][Full Text] [Related]
22. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691 [TBL] [Abstract][Full Text] [Related]
23. Atrial natriuretic peptide predicts impaired atrial remodeling and occurrence of late postoperative atrial fibrillation after surgery for symptomatic aortic stenosis. Yilmaz MB; Erbay AR; Balci M; Guray Y; Cihan G; Guray U; Kisacik HL; Korkmaz S Cardiology; 2006; 105(4):207-12. PubMed ID: 16498244 [TBL] [Abstract][Full Text] [Related]
24. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation. Wozakowska-Kaplon B; Opolski G Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S110-4. PubMed ID: 15683475 [TBL] [Abstract][Full Text] [Related]
25. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758 [TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation. Sielski J; Janion M; Gawor Z Kardiol Pol; 2005 Mar; 62(3):202-9; discussion 210. PubMed ID: 15830014 [TBL] [Abstract][Full Text] [Related]
28. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Schütte F; Lüdorff G; Grove R; Kranig W; Thale J Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399 [TBL] [Abstract][Full Text] [Related]
29. Correlation between left ventricular mass and the resting and post-exercise release of ANP in healthy men. Pawlicki L; Irzmański R; Rózalski S; Kowalski J; Kokot F Med Sci Monit; 2001; 7(5):903-7. PubMed ID: 11535932 [TBL] [Abstract][Full Text] [Related]
30. [Comparison of peripheral blood hematopoietic progenitor cells among patients with paroxysmal, permanent atrial fibrillation or sinus rhythm]. Wu WF; Fu CP Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):390-3. PubMed ID: 19100027 [TBL] [Abstract][Full Text] [Related]
31. [Cardiopulmonary stress test in patients with heart failure and atrial fibrillation]. Nessler J; Nessler B; Stopyra K; Gajos G; Piwowarska W Kardiol Pol; 2004 Sep; 61 Suppl 2():II76-81. PubMed ID: 20527422 [TBL] [Abstract][Full Text] [Related]
32. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
33. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251 [TBL] [Abstract][Full Text] [Related]
34. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
35. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. Sugawara A; Nakao K; Morii N; Yamada T; Itoh H; Shiono S; Saito Y; Mukoyama M; Arai H; Nishimura K J Clin Invest; 1988 Jun; 81(6):1962-70. PubMed ID: 2968368 [TBL] [Abstract][Full Text] [Related]
37. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function. Therkelsen SK; Groenning BA; Kjaer A; Svendsen JH; Boje Jensen G Int J Cardiol; 2008 Jul; 127(3):396-9. PubMed ID: 17628724 [TBL] [Abstract][Full Text] [Related]
38. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study. Fung JW; Sanderson JE; Yip GW; Zhang Q; Yu CM J Card Fail; 2007 Oct; 13(8):649-55. PubMed ID: 17923357 [TBL] [Abstract][Full Text] [Related]
39. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life]. Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578 [TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability. Nielsen OW; Rasmussen V; Christensen NJ; Hansen JF Scand J Clin Lab Invest; 2004; 64(7):619-28. PubMed ID: 15513318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]